SL
HAE icon

Savior LLC’s Haemonetics HAE Stock Holding History

Savior LLC’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-19
Closed -$1K – 434
2021
Q2 		$1K Hold
19
– – ﹤0.01% 796
2021
Q1 		$2K Hold
19
– – ﹤0.01% 744
2020
Q4 		$2K Hold
19
– – ﹤0.01% 716
2020
Q3 		$2K Hold
19
– – ﹤0.01% 680
2020
Q2 		$2K Hold
19
– – ﹤0.01% 642
2020
Q1 		$2K Hold
19
– – ﹤0.01% 628
2019
Q4 		$2K Buy
+19
New +$2.3K ﹤0.01% 746

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Savior LLC's HAE Position: Q3 2021 in Review

Savior LLC sold out of Haemonetics (HAE) in Q3 2021, closing a stake of 19 shares — an estimated $1K sold.

Savior LLC first reported a position in HAE in Q4 2019 and held it in 7 quarters. The position peaked at $2K in Q1 2021. 245 funds tracked by Wall St. Rank hold HAE as of Q3 2021.

  • Savior LLC reported no remaining Haemonetics position as of Q3 2021 after selling out during the quarter.
  • Savior LLC sold 19 Haemonetics shares in Q3 2021, an estimated $1K.
  • Savior LLC first reported a position in Haemonetics in Q4 2019 and held it in 7 quarters.
  • Savior LLC's Haemonetics position peaked at $2K in Q1 2021.
  • 245 funds tracked by Wall St. Rank held Haemonetics as of Q3 2021.

Based on Savior LLC's 13F filing for Q3 2021, filed 5 Oct 2021.